TNFRSF19 抗体 (AA 29-44)
-
- 抗原 See all TNFRSF19 抗体
- TNFRSF19 (Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19))
-
抗原表位
- AA 29-44
-
适用
- 人, 小鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This TNFRSF19 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 特异性
- This antibody recognizes TNFRSF19.
- 交叉反应 （详细）
-
Species reactivity (expected):Mouse.
Species reactivity (tested):Human. - 纯化方法
- Protein G Chromatography.
- 免疫原
- A mixture of synthetic peptides corresponding to amino acids 29-44, 204-219, and 409-421 of Human TROY.
- 亚型
- IgG
- Top Product
- Discover our top product TNFRSF19 Primary Antibody
-
anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 30-170) antibody
TNFRSF19 适用: 人 WB, ELISA, IHC, ICC, FACS, Neut 宿主: 小鼠 Monoclonal 6F5D3 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 35-160) antibodyTNFRSF19 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 30-119) antibodyTNFRSF19 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 1H6 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 276-415) antibodyTNFRSF19 适用: 人 WB, ELISA, IF 宿主: 兔 Polyclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 75-88), (Extracellular), (N-Term) antibodyTNFRSF19 适用: 人, 小鼠, 大鼠 WB, ICC, IF, LCI 宿主: 兔 Polyclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 41-161) antibodyTNFRSF19 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 30-119) antibodyTNFRSF19 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 1-417) antibodyTNFRSF19 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 75-88) antibodyTNFRSF19 适用: 小鼠 IHC 宿主: 兔 Polyclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (C-Term) antibodyTNFRSF19 适用: 人 WB, ELISA 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
Immunohistochemistry on Paraffin Sections: 5 μg/mL. Western blot: 0.5-2 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - 限制
- 仅限研究用
-
- 浓度
- 0.5 mg/mL
- 缓冲液
- PBS containing 0.02 % Sodium Azide as preservative.
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Avoid repeated freezing and thawing.
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
-
- 抗原
- TNFRSF19 (Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19))
- 别名
- TNFRSF19 / TRADE (TNFRSF19 产品)
- 别名
- TNFRSF19 antibody, DKFZp468A0320 antibody, TAJ antibody, TAJ-alpha antibody, TRADE antibody, TROY antibody, AL023044 antibody, AW123854 antibody, TAJ-ALPHA antibody, Troy antibody, RGD1564996 antibody, TNF receptor superfamily member 19 antibody, tumor necrosis factor receptor superfamily, member 19 antibody, TNFRSF19 antibody, Tnfrsf19 antibody
- 背景
- Analysis of EST clones and use of a signal sequence trap screening of the murine brain have lead to identification of a new member of the tumor necrosis factor receptor superfamily designated as TAJ and TROY, respectively. TAJ/TROY is a membrane protein of 423 amino acids with characteristic cysteine-rich motifs in the extracellular domain and a tumor necrosis factor receptor-associated factor (TRAF) 2 binding sequence in the cytoplasmic domain. Human TROY has 78 % identity at the amino acid level with mouse TROY. The extracellular domain of TROY has significant homology with that of EDAR (another newly identified receptor belonging to TNF receptor family) that specifies hair follicle fate. The cytoplasmic domain of TAJ is different than other TNF receptor family members. Although its cytoplasmic domain does not contain death domain, TAJ/TROY induced cell death is probably mediated through a caspase-independent pathway. TAJ-induced JNK activation was not blocked by dominant-negative inhibitors of TRAF2, TRAF5, or ASK1, which have been previously implicated in JNK activation via TNFR1 and CD40. However, coimmunoprecipitation assays revealed that TAJ is capable of binding a number of different TRAF family members, and it is possible that TAJ-induced JNKactivation is mediated by an as yet untested TRAF homolog, such as TRAF6. TROY mRNA is highly expressed in brain, prostate and embryo and moderately expressed in the heart, lung, liver.Synonyms: TAJ, TROY, Toxicity and JNK inducer, Tumor necrosis factor receptor superfamily member 19
- 基因ID
- 55504
- NCBI登录号
- NP_001191387
- UniProt
- Q9NS68
-
